A Study on the Characteristics of Healthy Volunteers who Participate in Phase I Clinical Trials in Korea

被引:3
|
作者
Seo, Ji-Hye [1 ]
Kim, Ock-Joo [1 ]
Yoo, Sang-Ho [2 ]
Choi, Eun Kyung [3 ]
Park, Ji-Eun [4 ]
机构
[1] Seoul Natl Univ, Dept Hist Med & Med Humanities, Coll Med, 103 Daehak Ro, Seoul 03080, South Korea
[2] Hanyang Univ, Dept Med Human & Eth, Coll Med, Seoul, South Korea
[3] Korea Natl Inst Bioeth Policy, Seoul, South Korea
[4] Korea Inst Oriental Med, KM Data Div, Daejeon, South Korea
关键词
phase I clinical trials; healthy volunteers; informed consent; research ethics;
D O I
10.1177/15562646211034275
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
The phase I trial is the first step in administering a drug to humans, but it has no therapeutic purpose. Under the absence of therapeutic purpose, healthy volunteers demonstrated different motivations, unlike the actual patients participating in trials. There were many reported motivations, such as financial motivation, contributing to the health science, accessing ancillary health care benefits, scientific interest or interest in the goals of the study, meeting people, and general curiosity. The aim of this study was to identify the motivation and characteristics of healthy volunteers participating in phase I trials in the Republic of Korea. We gave surveys to 121 healthy volunteers to study their demographic characteristics and the reasons of participation. We identified whether the decision to participate in the research was influenced by demographic factors and whether the perception and attitudes toward the research were influenced by the characteristics of the healthy volunteers. After completion of the first survey, 12 healthy volunteers who had participated in a phase I clinical trial were selected to answer the second interview. According to our survey, most healthy volunteers were unmarried men and economically dependent. Most of them participated in the study because of financial reward. The most important factor to measure financial reward was the research period. Also, 43% of the volunteers were university students, 42% answered "university graduation" and 55% were residing in family-owned houses. Many healthy volunteers were found to be living in family homes and to have a student status or lack of economic independence. Results of the survey showed that 64% of respondents indicated having more than one clinical trial participation. In-depth interviews showed that healthy volunteers had diverse motivation to participate in research and that healthy volunteer perceive the clinical trial positively. The main motivation for healthy volunteers' participation in research was "financial reward." Healthy volunteers also considered research schedules, processes, and safety, and had a positive perception of clinical trials, but they thought that the public has a negative perception.
引用
收藏
页码:193 / 212
页数:20
相关论文
共 50 条
  • [31] Stopped hearts, amputated toes and NASA: contemporary legends among healthy volunteers in US phase I clinical trials
    Fisher, Jill A.
    SOCIOLOGY OF HEALTH & ILLNESS, 2015, 37 (01) : 127 - 142
  • [32] Picking and Choosing Among Phase I Trials A Qualitative Examination of How Healthy Volunteers Understand Study Risks
    Fisher, Jill A.
    Monahan, Torin
    Walker, Rebecca L.
    JOURNAL OF BIOETHICAL INQUIRY, 2019, 16 (04) : 535 - 549
  • [33] WEIGHT OF FINANCIAL REWARD IN THE DECISION BY MEDICAL-STUDENTS AND EXPERIENCED HEALTHY-VOLUNTEERS TO PARTICIPATE IN CLINICAL-TRIALS
    BIGORRA, J
    BANOS, JE
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 38 (05) : 443 - 446
  • [34] The motivations, barriers, and sociodemographic characteristics of healthy Chinese volunteers in phase I research
    Wang, Zejuan
    Chen, Gang
    Liu, Xiaona
    Liu, Chen
    Song, Qingkun
    Wang, Jin
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (04) : 557 - 568
  • [35] The motivations, barriers, and sociodemographic characteristics of healthy Chinese volunteers in phase I research
    Zejuan Wang
    Gang Chen
    Xiaona Liu
    Chen Liu
    Qingkun Song
    Jin Wang
    European Journal of Clinical Pharmacology, 2021, 77 : 557 - 568
  • [36] Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds
    Radanovic, Igor
    Moerland, Matthijs
    Groeneveld, Geert Jan
    Bosch, Jacobus J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (03) : 1256 - 1257
  • [37] Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds
    Radanovic, Igor
    Klarenbeek, Naomi
    Rissmann, Robert
    Groeneveld, Geert Jan
    van Brummelen, Emilie M. J.
    Moerland, Matthijs
    Bosch, Jacobus J.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [38] Adverse publicity of serious side effects to healthy volunteers has limited effect on willingness-to-participate in clinical trials
    Molinari, Nicolas
    Suehs, Carey
    Vachier, Isabelle
    Pahus, Laurie
    Halimi, Laurence
    Gamez, Anne-Sophie
    Chanez, Pascal
    Bourdin, Arnaud
    CLINICAL TRIALS, 2019, 16 (04) : 440 - 442
  • [39] ADVISING AIDS PATIENTS WHO PARTICIPATE IN CLINICAL-TRIALS
    DELEONJONES, F
    ALLEN, AD
    CHRISS, D
    AIDS PATIENT CARE, 1994, 8 (01): : 33 - 34
  • [40] The views of patients and healthy volunteers on participation in clinical trials: An exploratory survey study
    Chu, Sang Hui
    Jeong, Seok Hee
    Kim, Eun Jung
    Park, Min Soo
    Park, Kyungsoo
    Nam, Moonsuk
    Shim, Jae Yong
    Yoon, Young-Ran
    CONTEMPORARY CLINICAL TRIALS, 2012, 33 (04) : 611 - 619